ANTX icon

AN2 Therapeutics
ANTX

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $99.9M invested in AN2 Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

81% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 16

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11M
2
+$8.59M
3
+$6.13M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$425K
5
PAG
Private Advisor Group
New Jersey
+$387K

Top Sellers

1
-$3.91M
2
-$782K
3
-$751K
4
State Street
State Street
Massachusetts
-$670K
5
APM
Avidity Partners Management
Texas
-$561K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$14.3K
27
$5.7K
28
$2K
29
$1.7K
30
$859
31
$298
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
1
2